FDX1 and nonpapillary renal cell carcinoma: Herein, our study indicated that the cuproptosis master regulator FDX1 was dramatically decreased in ccRCC tumors, which was further silenced as the tumors progressed to an advanced stage, suggesting that ccRCC tumors may poorly respond to copper-induced cell death and choose to inhibit physiological cuproptosis for better survival.